A detailed history of Rnc Capital Management LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Rnc Capital Management LLC holds 39,469 shares of AZN stock, worth $2.54 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
39,469
Previous 39,469 -0.0%
Holding current value
$2.54 Million
Previous $3.08 Million 0.1%
% of portfolio
0.17%
Previous 0.18%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$66.81 - $80.83 $213,524 - $258,332
3,196 Added 8.81%
39,469 $3.08 Million
Q1 2024

Aug 07, 2024

SELL
$61.03 - $69.57 $41,439 - $47,238
-679 Reduced 1.84%
36,273 $2.46 Million
Q4 2023

Jan 17, 2024

BUY
$61.89 - $69.28 $65,293 - $73,090
1,055 Added 2.94%
36,952 $2.49 Million
Q3 2023

Dec 27, 2023

SELL
$64.85 - $71.7 $45,070 - $49,831
-695 Reduced 1.9%
35,897 $2.43 Million
Q2 2023

Jul 20, 2023

SELL
$69.91 - $75.81 $4.03 Million - $4.37 Million
-57,584 Reduced 61.15%
36,592 $2.62 Million
Q1 2023

Apr 21, 2023

SELL
$63.15 - $71.6 $280,954 - $318,548
-4,449 Reduced 4.51%
94,176 $6.54 Million
Q4 2022

Jan 10, 2023

SELL
$54.21 - $70.44 $125,279 - $162,786
-2,311 Reduced 2.29%
98,625 $6.69 Million
Q3 2022

Oct 18, 2022

SELL
$53.02 - $135.75 $21,420 - $54,843
-404 Reduced 0.4%
100,936 $5.54 Million
Q2 2022

Jul 22, 2022

BUY
$59.26 - $71.14 $929,315 - $1.12 Million
15,682 Added 18.31%
101,340 $6.7 Million
Q1 2022

Jul 22, 2022

BUY
$55.72 - $67.12 $1.83 Million - $2.2 Million
32,802 Added 62.06%
85,658 $5.68 Million
Q4 2021

Feb 04, 2022

SELL
$54.02 - $63.83 $1.06 Million - $1.26 Million
-19,713 Reduced 27.16%
52,856 $3.08 Million
Q3 2021

Nov 02, 2021

BUY
$55.56 - $60.79 $2.47 Million - $2.7 Million
44,449 Added 158.07%
72,569 $4.36 Million
Q2 2021

Jul 20, 2021

BUY
$48.42 - $60.18 $1.36 Million - $1.69 Million
28,120 New
28,120 $1.68 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $200B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Rnc Capital Management LLC Portfolio

Follow Rnc Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rnc Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rnc Capital Management LLC with notifications on news.